Senhwa Biosciences Signs Major Strategic MOU with Y Combinator-Backed AI Biotech Company CellType to Accelerate the Evolution of CX-4945 into Version 2.0 and Reshape the Global Immunotherapy Landscape
TAIPEI and SAN DIEGO, March 3, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced the...
AI Innovation to Reshape Asia's Legal Sector - Talent, Governance, Technology
Legal Innovation Festival SE Asia 2026 to Address Challenges, Opportunities SINGAPORE, Feb. 4, 2026 /PRNewswire/ -- Artificial intelligence is having a growing impact on the Singapore legal profession. Insights from the recently released Legal...